. Author manuscript; available in PMC: 2017 Apr 1.

Published in final edited form as: J Vasc Surg. 2016 Jan 12;63(4):895–901. doi: 10.1016/j.jvs.2015.10.088

Table IV.

Development of persistent or new type 2 endoleaks at procedure and at follow-up by graft type.

	Type II Endoleak at procedure			Type II Endoleak at Follow-up

	N	total	%	N	total	%
AneurRx	86	257	33.5%	27	257	10.5%
Endurant	61	194	31.4%	17	194	8.8%
Excluder Low-Permeability	175	747	23.4%	167	747	22.4%
Powerlink	60	289	20.8%	23	289	8.0%
Talent	61	147	41.5%	8	147	5.4%
Zenith	124	537	23.1%	76	537	14.2%

Grafts with fewer than 100 implants were not included in this analysis (Ancure, Excluder Original, MEGS/VI, Cordis, Aorfix, Zenith Low Profile, AFX, Endurant II, Zenith Flex, Other)